{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:59:18Z","timestamp":1790888358064,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T00:00:00Z","timestamp":1269561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/hr.2010.35","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T09:48:37Z","timestamp":1269596917000},"page":"521-528","source":"Crossref","is-referenced-by-count":86,"title":["The role of sympathetic nervous activity in renal injury and end-stage renal disease"],"prefix":"10.1038","volume":"33","author":[{"given":"Kazuko","family":"Masuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin W","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray D","family":"Esler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,26]]},"reference":[{"key":"BFhr201035_CR1","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/01.HYP.34.4.724","volume":"34","author":"G Mancia","year":"1999","unstructured":"Mancia G, Grassi G, Giannattasio C, Seravalle G . Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34: 724\u2013728.","journal-title":"Hypertension"},{"key":"BFhr201035_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"31","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T . Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 31: 819\u2013823.","journal-title":"N Engl J Med"},{"key":"BFhr201035_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/01.CIR.94.4.690","volume":"94","author":"CR Benedict","year":"1996","unstructured":"Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Koustam M, Probstfield JL, Yusuf S . For the SOLVD investigators. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94: 690\u2013697.","journal-title":"Circulation"},{"key":"BFhr201035_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.jrn.2007.10.024","volume":"18","author":"A Ksiazek","year":"2008","unstructured":"Ksiazek A, Zatuska W . Sympathetic overactivity in uremia. J Ren Nutr 2008; 18: 118\u2013121.","journal-title":"J Ren Nutr"},{"key":"BFhr201035_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/00004872-200206000-00031","volume":"20","author":"MJ Petersson","year":"2002","unstructured":"Petersson MJ, Rundqvist B, Johansson M, Eisenhofer G, Lambert G, Herliz H, Jensen G, Friberg P . Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens 2002; 20: 1181\u20131187.","journal-title":"J Hypertens"},{"key":"BFhr201035_CR6","first-page":"1","volume":"854","author":"Report of a WHO Expert Committee","year":"1995","unstructured":"Report of a WHO Expert Committee. Physiological status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser 1995; 854: 1\u2013452.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"BFhr201035_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1053\/j.ackd.2004.10.009","volume":"12","author":"SL White","year":"2005","unstructured":"White SL, Caas A, Atkins RC, Chadban SJ . Chronic kidney disease in the general population. Adv Chronic Dis 2005; 12: 5\u201313.","journal-title":"Adv Chronic Dis"},{"key":"BFhr201035_CR8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11906-003-0084-z","volume":"5","author":"JE Hall","year":"2003","unstructured":"Hall JE, Jones DW, Kuo JJ, de Silva A, Tallam LS, Liu J . Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 2003; 5: 386\u2013392.","journal-title":"Curr Hypertens Rep"},{"key":"BFhr201035_CR9","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/hc1102.105261","volume":"105","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto AB, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, seminara G, Cateliotti A, Stancanelli B, Malatino S . Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354\u20131359.","journal-title":"Circulation"},{"key":"BFhr201035_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","volume":"65","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S . Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870\u20131876.","journal-title":"Kidney Int"},{"key":"BFhr201035_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-122-7-199504010-00001","volume":"122","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Willett WC, Rotnizky A, Manson JE . Weight gain as a risk for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481\u2013486.","journal-title":"Ann Intern Med"},{"key":"BFhr201035_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J . The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167\u2013174.","journal-title":"Ann Intern Med"},{"key":"BFhr201035_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","volume":"16","author":"RJ Garrison","year":"1987","unstructured":"Garrison RJ, Kannel WB, Stokes III J, Castelli WP . Incidence and precursors of hypertension in young adults: the Framingham offspring study. Prev Med 1987; 16: 235\u2013251.","journal-title":"Prev Med"},{"key":"BFhr201035_CR14","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/ndt\/gfn232","volume":"23","author":"Y Tsukamoto","year":"2008","unstructured":"Tsukamoto Y . End-stage renal disease (ESRD) and its treatment in Japan. Nephron Dial Transplant 2008; 23: 2447\u20132450.","journal-title":"Nephron Dial Transplant"},{"key":"BFhr201035_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/01.HYP.35.5.1135","volume":"35","author":"K Masuo","year":"2000","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck ML . Weight gain-induced blood pressure elevation. Hypertension 2000; 35: 1135\u20131140.","journal-title":"Hypertension"},{"key":"BFhr201035_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","volume":"42","author":"K Masuo","year":"2003","unstructured":"Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML . Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474\u2013480.","journal-title":"Hypertension"},{"key":"BFhr201035_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0895-7061(96)00303-2","volume":"10","author":"K Masuo","year":"1997","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck ML . Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in young, nonobese Japanese population. Am J Hypertens 1997; 10: 77\u201383.","journal-title":"Am J Hypertens"},{"key":"BFhr201035_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.HYP.32.1.96","volume":"32","author":"K Masuo","year":"1998","unstructured":"Masuo K, Mikaki H, Ogihara T, Tuck ML . Familial hypertension, insulin, sympathetic activity and blood pressure elevation. Hypertension 1998; 32: 96\u2013100.","journal-title":"Hypertension"},{"key":"BFhr201035_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/08037050152669701","volume":"10","author":"K Masuo","year":"2001","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck ML . Familial obesity, sympathetic activation and blood pressure level. Blood Press 2001; 10: 199\u2013204.","journal-title":"Blood Press"},{"key":"BFhr201035_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11906-002-0035-0","volume":"4","author":"K Masuo","year":"2002","unstructured":"Masuo K . Obesity-related hypertension: role of the sympathetic nervous system,insulin, asnd leptin. Curr Hypertens Rep 2002; 4: 112\u2013118.","journal-title":"Curr Hypertens Rep"},{"key":"BFhr201035_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1291\/hypres.30.503","volume":"30","author":"K Masuo","year":"2007","unstructured":"Masuo K, Katsuya T, Sugimoto K, Kawaguchi H, Rakugi H, Ogihara T, Tuck ML . High plasma norepinephrine levels associated with \u03b22-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals. Hypertens Res 2007; 30: 503\u2013511.","journal-title":"Hypertens Res"},{"key":"BFhr201035_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","volume":"40","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino S . Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 2002; 40: 41\u201346.","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"BFhr201035_CR23","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1291\/hypres.18.SupplementI_S201","volume":"18","author":"K Masuo","year":"1995","unstructured":"Masuo K, Mikami H, Ogihara T, Tuck M . Hormonal mechanisms in blood pressure reduction during hemodialysis in patients with chronic renal failure. Hypertens Res 1995; 18 (Suppl 1): S201\u2013S-203.","journal-title":"Hypertens Res"},{"key":"BFhr201035_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/157340208784245839","volume":"4","author":"K Masuo","year":"2008","unstructured":"Masuo K, Lambert GW, Rakugi H, Ogihara T, Esler MD . Neurovascular role of sympathetic nervous system and beta-adrenoceptor polymorphisms in obesity and hypertension. Curr Hypertens Reviews 2008; 4: 121\u2013130.","journal-title":"Curr Hypertens Reviews"},{"key":"BFhr201035_CR25","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1161\/CIRCULATIONAHA.104.519652","volume":"111","author":"K Masuo","year":"2005","unstructured":"Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML . Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005; 111: 3429\u20133434.","journal-title":"Circulation"},{"key":"BFhr201035_CR26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.amjhyper.2005.01.006","volume":"8","author":"K Masuo","year":"2005","unstructured":"Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML . Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. Am J Hypertens 2005; 8: 1009\u20131014.","journal-title":"Am J Hypertens"},{"key":"BFhr201035_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.amjhyper.2006.02.015","volume":"19","author":"K Masuo","year":"2006","unstructured":"Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML . Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. Am J Hypertens 2006; 19: 1084\u20131091.","journal-title":"Am J Hypertens"},{"key":"BFhr201035_CR28","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1291\/hypres.29.951","volume":"29","author":"K Masuo","year":"2006","unstructured":"Masuo K, Katsuya T, Kawaguchi H, Sugimoto K, Rakugi H, Ogihara T, Tuck ML . Beta2- and beta3-adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Hypertens Res 2006; 29: 951\u2013959.","journal-title":"Hypertens Res"},{"key":"BFhr201035_CR29","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/00004872-199816090-00014","volume":"16","author":"R Bigazzi","year":"1998","unstructured":"Bigazzi R, Bianchi S, Baldari D, Campese VM . Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325\u20131333.","journal-title":"J Hypertens"},{"key":"BFhr201035_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/01.hjh.0000209991.48928.c4","volume":"24","author":"J Schrader","year":"2006","unstructured":"Schrader J, Luders S, kulschewski A, Hammersen F, Zuchner C, Venneklass U, Schrandt G, Schneider M, Rangoonwala B, Berger J, Dominiak P, Zidek W . Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens 2006; 24: 541\u2013548.","journal-title":"J Hypertens"},{"key":"BFhr201035_CR31","first-page":"530","volume":"2","author":"JS Yudkin","year":"1988","unstructured":"Yudkin JS, Forrest RD, Jackson CA . Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey Lancet 1988; 2: 530\u2013533.","journal-title":"Islington Diabetes Survey Lancet"},{"key":"BFhr201035_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/HYPERTENSIONAHA.107.109264","volume":"52","author":"P Farbom","year":"2008","unstructured":"Farbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L, Kjeldsen S, Hender T, Melander O . Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the Nordic Diltiazen Study. Hypertension 2008; 52: 115\u2013122.","journal-title":"Hypertension"},{"key":"BFhr201035_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"HL Hillege","year":"2000","unstructured":"Hillege HL, Girbes ARJ, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ . Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203\u2013210.","journal-title":"Circulation"},{"key":"BFhr201035_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1524-6175.2006.05569.x","volume":"8","author":"FJ Mena-Martin","year":"2006","unstructured":"Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Castrodeza Sanz JJ, Hortega Study Investigators. Influence of asympathetic activity on blood pressure and vascular damage evaluated by means of urinary albumin excretion. J Clin Hypertens (Greenwich) 2006; 8: 619\u2013624.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"BFhr201035_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/HYPERTENSIONAHA.106.081679","volume":"49","author":"F Rao","year":"2007","unstructured":"Rao F, Wessel J, Wen G, Zhang L, Rana BK, Kennedy BP, Greenwood TA, Salem RM, Chen Y, Chen Y, Khandrika S, Hamilton BA, Smith DW, Holstein-Rathlou NH, Ziegler MG, Schork NJ, O\u2019Connor DT . Renal albumin excretion. Twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 2007; 49: 1015\u20131031.","journal-title":"Hypertension"},{"key":"BFhr201035_CR36","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2008040402","volume":"20","author":"MP Schlaich","year":"2009","unstructured":"Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW . Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20: 933\u2013939.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr201035_CR37","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","volume":"106","author":"M Hausberg","year":"2002","unstructured":"Hausberg M, kosch M, Hamelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Dahn KH . Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974\u20131979.","journal-title":"Circulation"},{"key":"BFhr201035_CR38","doi-asserted-by":"publisher","first-page":"H2302","DOI":"10.1152\/ajpheart.01029.2002","volume":"284","author":"P Jacob","year":"2003","unstructured":"Jacob P, Ariza P, Osborn JW . Renal denervation chronically lower arterial pressure independent of dietary sodium intake in normal rats. Am J Physiol Heart Circ Physiol 2003; 284: H2302\u2013H2310.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Part 2","key":"BFhr201035_CR39","first-page":"625","volume":"41","author":"JE Hall","year":"2003","unstructured":"Hall JE . The kidney, hypertension, and obesity. Hypertension 2003; 41 (Part 2): 625\u2013633.","journal-title":"Hypertension"},{"key":"BFhr201035_CR40","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0895-7061(97)00075-7","volume":"10","author":"JE Hall","year":"1997","unstructured":"Hall JE . Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10: S49\u2013S55.","journal-title":"Am J Hypertens"},{"key":"BFhr201035_CR41","doi-asserted-by":"publisher","first-page":"R434","DOI":"10.1152\/ajpregu.2001.281.2.R434","volume":"281","author":"TE Lohmeier","year":"2001","unstructured":"Lohmeier TE, Lohmeier JR, Reckelhoff JF, Hildebrandt DA . Sustained influence of the renal nerves to attenuate sodium intake retention in angiotensin hypertension. Am J Physiol Regul Interg Comp Physiol 2001; 281: R434\u2013R443.","journal-title":"Am J Physiol Regul Interg Comp Physiol"},{"key":"BFhr201035_CR42","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/HYPERTENSIONAHA.107.100800","volume":"51","author":"SL Burke","year":"2008","unstructured":"Burke SL, Evans RG, Moretti JL, Head GA . Levels of renal and extrarenal sympathetic drive in angiotensin II-induced hypertension. Hypertension 2008; 51: 878\u2013883.","journal-title":"Hypertension"},{"key":"BFhr201035_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1440-1681.2005.04204.x","volume":"32","author":"JK Philips","year":"2005","unstructured":"Philips JK . Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol 2005; 32: 415\u2013418.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr201035_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/HJH.0b013e32831fb371","volume":"27","author":"G Grassi","year":"2009","unstructured":"Grassi G, Seravalle G, Arenare F, Buccianti G, Furiani S, Ilardo V, Bolla G, Mancia G . Behaviour of regional adrenergic outflow in mild-to-moderate renal failure. J Hypertens 2009; 27: 562\u2013566.","journal-title":"J Hypertens"},{"key":"BFhr201035_CR45","doi-asserted-by":"publisher","first-page":"H1577","DOI":"10.1152\/ajpheart.00218.2002","volume":"283","author":"C Erami","year":"2002","unstructured":"Erami C, Zhang H, Ho JG, French DM, Faber JE . 1-adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol Heart Circ Physiol 2002; 283: H1577\u2013H1587.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201035_CR46","first-page":"67","volume-title":"Sympathetic Neorvous System Research Developments","author":"K Masuo","year":"2007","unstructured":"Masuo K, Straznicky NE, Lambert GW, Esler MD . Obesity and obesity-related hypertension: Role of the sympathetic nervous system and \u03b2-adrenoceptor polymorphisms. In: Kaneko M (ed). Sympathetic Neorvous System Research Developments. Nova Science Publishers: New York, 2007, pp 67\u201392."},{"key":"BFhr201035_CR47","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1210\/jc.2005-0961","volume":"90","author":"NE Straznicky","year":"2005","unstructured":"Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestle PJ . Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 5998\u20136005.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr201035_CR48","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/01.HYP.0000242642.42177.49","volume":"48","author":"M Esler","year":"2006","unstructured":"Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E . Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 787\u2013796.","journal-title":"Hypertension"},{"key":"BFhr201035_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2337\/diabetes.51.1.168","volume":"51","author":"C Vecchione","year":"2002","unstructured":"Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Trimarco B, Lembo G . Leptin effects on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002; 51: 168\u2013173.","journal-title":"Diabetes"},{"key":"BFhr201035_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2337\/diabetes.49.2.293","volume":"49","author":"G Lembo","year":"2000","unstructured":"Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, D\u2019Amati G, Trimarco B . Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000; 49: 293\u2013297.","journal-title":"Diabetes"},{"key":"BFhr201035_CR51","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/oby.2002.128","volume":"10","author":"J Beltowski","year":"2002","unstructured":"Beltowski J, Wojcicka G, Borkowska E . Human leptin stimulates systemic nitric oxide production in the rat. Obes Res 2002; 10: 939\u2013946.","journal-title":"Obes Res"},{"key":"BFhr201035_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000183467","volume":"40","author":"DE Wesson","year":"1985","unstructured":"Wesson DE, Kurtzman NA, Prommer JP . Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron 1985; 40: 235\u2013237.","journal-title":"Nephron"},{"key":"BFhr201035_CR53","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1097\/01.ASN.0000098687.01005.A5","volume":"14","author":"IH Klein","year":"2003","unstructured":"Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ . Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003; 14: 3239\u20133244.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr201035_CR54","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(76)92165-6","volume":"1","author":"JJ Brown","year":"1976","unstructured":"Brown JJ, Davies DL, Morton JJ, Robertson JI, Cuesta V, Lever AF, Padfield PL, Trust P . Mechanism of renal hypertension. Lancet 1976; 1: 1219\u20131221.","journal-title":"Lancet"},{"key":"BFhr201035_CR55","doi-asserted-by":"publisher","first-page":"I-139","DOI":"10.1161\/01.HYP.5.2_Pt_2.I139","volume":"5","author":"H Suzuki","year":"1983","unstructured":"Suzuki H, Ferrario CM, Speth RC, Brosnihan KB, Smeby RR, de Silva P . Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension 1983; 5: I-139\u2013I-148.","journal-title":"Hypertension"},{"key":"BFhr201035_CR56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/01.HYP.17.6.1057","volume":"17","author":"E Miyajima","year":"1997","unstructured":"Miyajima E, Yamada Y, Toshida Y, Matsuoka T, Shionoiri H, Tochikubo O, Ishi M . Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1997; 17: 1057\u20131062.","journal-title":"Hypertension"},{"key":"BFhr201035_CR57","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/01.CIR.99.19.2537","volume":"99","author":"M Johansson","year":"1999","unstructured":"Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, Friberg P . Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99: 2357\u20132542.","journal-title":"Circulation"},{"key":"BFhr201035_CR58","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00005344-198608005-00008","volume":"8","author":"M Esler","year":"1986","unstructured":"Esler M, Jennings G, Biviano B, Lambert G, Haking G . Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 1986; 8: 539\u2013544.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr201035_CR59","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1440-1681.2007.04754.x","volume":"34","author":"NB Ojeda","year":"2007","unstructured":"Ojeda NB, Johnson WR, Dwyer TM, Alexander BT . Early renal denervation prevents development of hypertension in growth-restricted offspring. Clin Exp Pharmacol Physiol 2007; 34: 1212\u20131216.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr201035_CR60","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, Sobotka DA, Sadowski J, Bertus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M . Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275\u20131281.","journal-title":"Lancet"},{"key":"BFhr201035_CR61","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.109.138610","volume":"54","author":"MP Schlaich","year":"2009","unstructured":"Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD . Renal denervation as a therapeutic approach for hypertension. Novel implications for an old concept. Hypertension 2009; 54: 1195\u20131201.","journal-title":"Hypertension"},{"key":"BFhr201035_CR62","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1440-1681.2006.04514.x","volume":"33","author":"MD Hendel","year":"2006","unstructured":"Hendel MD, Collister JP . Renal denervation attenuates long-term hypertensive effects of angiotensin II in the rat. Clin Exp Pharmacol Physiol 2006; 33: 1225\u20131230.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr201035_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pcad.2009.09.003","volume":"52","author":"RE Katholi","year":"2009","unstructured":"Katholi RE, Rocha-Singh KJ . The role of renal sympathetic nerves in hypertension: has percutaneus renal denervation refocused attention on their clinical significance? Prog Cardiovasc Dis 2009; 52: 243\u2013248.","journal-title":"Prog Cardiovasc Dis"},{"key":"BFhr201035_CR64","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/01.HYP.0000253507.56499.bb","volume":"49","author":"TE Lohmeier","year":"2007","unstructured":"Lohmeier TE, Hildebrandt DA, Dwyer TM, Barrett AM, Irwin ED, Rossing MA, Kieval RS . Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension 2007; 49: 373\u2013379.","journal-title":"Hypertension"},{"key":"BFhr201035_CR65","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E Wuhi","year":"2009","unstructured":"Wuhi E, Trivelli A, Picca S, litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Moller K, Wigger M, Peruzzi L, Mehis O, Schaefer F . Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639\u20131650.","journal-title":"N Engl J Med"},{"key":"BFhr201035_CR66","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.clinthera.2007.09.019","volume":"29","author":"MR Weir","year":"2007","unstructured":"Weir MR . Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Clin Ther 2007; 29: 1803\u20131824.","journal-title":"Clin Ther"},{"key":"BFhr201035_CR67","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/01.HYP.0000256530.39695.a3","volume":"49","author":"J Neumann","year":"2007","unstructured":"Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, Blankestijn PJ . Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007; 49: 506\u2013510.","journal-title":"Hypertension"},{"key":"BFhr201035_CR68","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/01.ASN.0000045049.72965.B7","volume":"14","author":"IH Klein","year":"2003","unstructured":"Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ . Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 2003; 14: 425\u2013430.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"BFhr201035_CR69","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/archinternmed.2009.60","volume":"169","author":"Jackson T. Wright","year":"2009","unstructured":"Wright JT Jr, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, Einhorn PT, Rahman M, Whelton PK, Ford CE, Haywood LJ, Margolis KL, Oparil S, Black HR, Alderman MH, ALLHAT Collaborative Research Group. ALLHAT findings revised in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med 2009; 169: 832\u2013842.","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 2","key":"BFhr201035_CR70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00003495-200565002-00005","volume":"65","author":"RR Wenzel","year":"2005","unstructured":"Wenzel RR . Renal protection in hypertensive patients: selection of antihypertensive therapy. Drug 2005; 65 (Suppl 2): 29\u201339.","journal-title":"Drug"},{"key":"BFhr201035_CR71","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","volume":"340","author":"G Ligtenberg","year":"1999","unstructured":"Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA . Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321\u20131328.","journal-title":"N Engl J Med"},{"key":"BFhr201035_CR72","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1681\/ASN.V1181469","volume":"11","author":"K Amann","year":"2000","unstructured":"Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, Gross ML, Koch A, Bielenberg GW, Van Kats JP, Ehmke H, Mall G, Ritz E . Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomised rats. J Am Soc Nephrol 2000; 11: 1469\u20131478.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr201035_CR73","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1161\/01.HYP.0000190585.54734.48","volume":"46","author":"GL Bakris","year":"2005","unstructured":"Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright Jr JT, Waterhouse B, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators. Different effects of beta-blockers on albuminuria in patients with type 2 diabetes. Hypertension 2005; 46: 1309\u20131315.","journal-title":"Hypertension"},{"key":"BFhr201035_CR74","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","volume":"292","author":"GL Bakris","year":"2004","unstructured":"Bakris GL, Fonseca V, Katholl RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright Jr JT, Oakes R, Lukas MA, Anderson KM, Bell DS, GEMINI Investigators. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004; 292: 2227\u20132236.","journal-title":"JAMA"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201035","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:07:05Z","timestamp":1684429625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,26]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFhr201035"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.35","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,26]]}}}